EGFR-IN-62

EGFR-IN-62 is a potent and selective EGFR kinase inhibitor effective against wild-type and mutant forms, including L858R/T790M and L858R/T790M/C797S. It demonstrates anti-proliferative activity by inducing cell cycle arrest, apoptosis, and inhibiting motility in non-small cell lung cancer cell lines such as A549 and H1975, making it a valuable tool for oncology research.